Compounds > cyclosporine

cyclosporine and Coronary Artery Disease

cyclosporine has been researched along with Coronary Artery Disease in 58 studies

Research

Studies (58)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's29 (50.00)18.2507
2000's18 (31.03)29.6817
2010's8 (13.79)24.3611
2020's3 (5.17)2.80

Authors

AuthorsStudies
Furui, S; Matsubara, D; Minami, T; Oka, K; Sato, T; Seki, M; Suzuki, S; Yamagata, T; Yokomizo, A1
Akande, O; Chen, Q; Cholyway, R; Lesnefsky, EJ; Quader, M; Toldo, S1
Andreassen, AK; Arora, S; Aukrust, P; Bøtker, HE; Dellgren, G; Eiskjær, H; Gude, E; Gullestad, L; Gustafsson, F; Ioanes, D; Karason, K; Rådegran, G; Solbu, D; Ueland, T1
McCrindle, BW; Rowley, AH1
Andersson, B; Andreassen, AK; Arora, S; Dellgren, G; Eiskjær, H; Gude, E; Gullestad, L; Gustafsson, F; Jansson, K; Karason, K; Rådegran, G; Solbu, D1
Burns, JC1
Andreassen, AK; Arora, S; Aukrust, P; Berge, RK; Broch, K; Dellgren, G; Gude, E; Gullestad, L; Hov, JR; Karason, K; Mayerhofer, CCK; Svardal, A; Trøseid, M; Ueland, T1
Eifert, S; Grinninger, C; Groetzner, J; Guethoff, S; Hagl, C; Kaczmarek, I; Meiser, BM; Reichart, B; Ueberfuhr, P1
Akashima, T; Amano, J; Isobe, M; Ito-Amano, M; Suzuki, J; Terasaki, T; Wada, Y1
Bandorski, D; Bogossian, H; Eckardt, L; Frommeyer, G; Kafchitsas, K; Lemke, B; Matzaroglou, C; Ninios, I; Seyfarth, M; Zarse, M1
Edwards, BS; Frantz, RP; Kushwaha, SS; Lennon, RJ; Lerman, A; Prasad, A; Raichlin, E; Rihal, CS1
Bergan, S; Eiskjaer, H; Fagertun, HE; Iversen, M; Mared, L; Nilsson, F; Nyström, U; Simonsen, S; Sipponen, J; Solbu, D1
Chen, YS; Chi, NH; Chou, NK; Chu, SH; Huang, SC; Jan, CF; Ko, WJ; Lee, CM; Tsao, CI; Wang, SS; Wu, IH; Yu, HY1
Miller, LW1
Mohr, FW; Olbrich, HG; Richter, HR; Richter, MH1
Burke, E; Burkhoff, D; Edwards, N; Itescu, S; LaManca, J; Mancini, D; Marks, AR; Oz, M; Pinney, S1
Fischereder, M; Hengstenberg, C; Kammerl, MC; Krämer, BK; Marienhagen, J; Schmidt, C; Zülke, C1
Chan, MC; Gao, SZ; Hunt, SA; Robbins, RC; Shiba, N; Valantine, HA1
Laher, I; McManus, BM; Moien-Afshari, F1
Chan, MC; Hunt, SA; Kwok, BW; Robbins, RC; Shiba, N; Valantine, HA1
Bilińska, M; Wolszakiewicz, J1
Czer, LS; Kamlot, A; Luthringer, D; Quartel, A; Soukiasian, HJ; Trento, A; Wang, C; Wang, HM1
Cooke, DT; Hoyt, EG; Kown, MH; Lijkwan, MA; Martens, JM; Murata, S; Peterson, SH; Robbins, RC1
Balsam, LB; Cooke, DT; Kofidis, T; Mokhtari, GK; Robbins, RC; Tanaka, M; Zwierzchonievska, M1
Bernstein, D; Burge, M; Chin, C; Gamberg, P; Kouretas, P; Miller, J; Reitz, B; Robbins, R; Ross, M1
Libby, P; Schoen, FJ; Sukhova, G; Swanson, SJ; Tanaka, H1
Gmiński, J; Stajszczyk, M1
Nagamine, S1
Bouchard, D; Carrier, M; Cartier, R; Despatis, MA; Leung, TK1
Esato, K; Fujimura, Y; Gohra, H; Hamano, K; Ito, H; Katoh, T; Shirasawa, B; Suzuki, K; Tsuboi, H1
Bierhaus, A; Dürfeld, F; Haberbosch, W; Heidinger, K; Hölschermann, H; Lohmeyer, J; Maus, U; Nawroth, PP; Tillmanns, H1
Foegh, ML; Katz, N; Kodama, T; Lou, H; Ramwell, P; Wang, YN1
Foegh, ML; Katz, N; Kodama, T; Lou, H; Maurice, P; Wang, YN; Zhao, YJ1
Koskinen, PK; Lemström, KB1
Mauro, VF; Southworth, MR1
Esper, E; Filer, SR; Glagov, S; Karp, RB; Sand, ME; Scanu, AM; Simonsen, KK1
Augustine, S; Chen, CL; Hruban, RH; Lafond-Walker, A; Lowenstein, CJ; Wu, TC1
Bouchard, D; Buluran, J; Cartier, R; Despatis, MA1
Poston, RS; Reitz, BA; Robbins, RC; Teranishi, K1
Asagami, T; Cooke, JP; Poston, RS; Reitz, BA; Robbins, RC; Teranishi, K; Tsao, PS1
Hachida, M; Hoshi, H; Koyanagi, H; Lu, H; Zhang, XL2
Aziz, TM; Campbell, C; Deiraniya, A; Dyer, P; el-Gamel, A; Krysiak, P; Rahman, A; Sheldon, S; Yonan, N1
Esato, K; Fujimura, Y; Gohra, H; Hamano, K; Ito, H; Katoh, T; Zempo, N1
Esato, K; Fujimura, Y; Hamano, K; Ito, H; Suzuki, K1
Hachida, M; Hoshi, H; Koyanagi, H; Lu, H; Zhang, X2
Annalisa, A; Antonio, G; Massimo, F; Maurizio, PG; Panagiotis, T; Sara, P; Sartori, TM; Ugolino, L1
Furukawa, Y; Hara, M; Hwang, MW; Iwasaki, A; Matsumori, A; Okada, M; Ono, K; Sasayama, S1
Furutani, Y; Hachida, M; Hoshi, H; Koyanagi, H; Lu, H; Matsuoka, R; Saito, S; Zhang, X1
Carrier, M; Pellerin, M; Pelletier, GB; Pelletier, LC; Perrault, LP; Robitaille, D; White, M1
Klauss, V; König, A; Theisen, K1
Levi, M; Moons, AH; Peters, RJ1
Mohr, FW; Olbrich, HG; Richter, H; Richter, M; Schramm, D; Skupin, M; Weinert, M1
Bartels, A; Breithardt, G; Hohage, H; Plenz, G; Schmidt, A; Sindermann, JR; Skaletz-Rorowski, A1
Esato, K; Hamano, K; Ueki, K1
Jamieson, SW1

Reviews

6 review(s) available for cyclosporine and Coronary Artery Disease

ArticleYear
Cardiovascular toxicities of immunosuppressive agents.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2002, Volume: 2, Issue:9

    Topics: Adrenal Cortex Hormones; Animals; Cardiovascular System; Coronary Artery Disease; Cyclosporine; Diabetes Mellitus; Humans; Hyperlipidemias; Hypertension; Immunosuppressive Agents; Sirolimus; Tacrolimus

2002
Immunosuppression and transplant vascular disease: benefits and adverse effects.
    Pharmacology & therapeutics, 2003, Volume: 100, Issue:2

    Topics: Animals; Coronary Artery Disease; Cyclosporine; Heart Transplantation; Humans; Immunosuppressive Agents

2003
[Transplant coronary artery disease--treatment with statins].
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2004, Volume: 16, Issue:95

    Topics: Coronary Artery Disease; Cyclosporine; Cytochrome P-450 Enzyme System; Drug Interactions; Heart Transplantation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Rhabdomyolysis

2004
[Cyclosporin and atherosclerosis].
    Polskie Archiwum Medycyny Wewnetrznej, 1994, Volume: 92, Issue:1

    Topics: Animals; Coronary Artery Disease; Cyclosporine; Heart Transplantation; Humans; Immunosuppression Therapy

1994
The use of HMG-CoA reductase inhibitors to prevent accelerated graft atherosclerosis in heart transplant patients.
    The Annals of pharmacotherapy, 1997, Volume: 31, Issue:4

    Topics: Coronary Artery Disease; Cyclosporine; Drug Interactions; Graft Rejection; Heart Transplantation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Randomized Controlled Trials as Topic

1997
Tissue factor and coronary artery disease.
    Cardiovascular research, 2002, Feb-01, Volume: 53, Issue:2

    Topics: Acute Disease; Angioplasty, Balloon, Coronary; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Anticoagulants; Arginine; Aspirin; Coronary Artery Disease; Coronary Thrombosis; Cyclosporine; Endothelium, Vascular; Factor VIIa; Heparin, Low-Molecular-Weight; Hirudin Therapy; Humans; Hypolipidemic Agents; Leukocytes, Mononuclear; Muscle, Smooth, Vascular; Recombinant Proteins; Thrombin; Thromboplastin

2002

Trials

6 trial(s) available for cyclosporine and Coronary Artery Disease

ArticleYear
Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Heart Transplant Recipients.
    Circulation. Heart failure, 2018, Volume: 11, Issue:9

    Topics: Adult; Allografts; Calcineurin Inhibitors; Coronary Angiography; Coronary Artery Disease; Cyclosporine; Drug Administration Schedule; Everolimus; Female; Graft Rejection; Graft Survival; Heart Transplantation; Humans; Immunosuppressive Agents; Inflammation Mediators; Male; Middle Aged; Plaque, Atherosclerotic; Prospective Studies; Scandinavian and Nordic Countries; Time Factors; Treatment Outcome; Ultrasonography, Interventional

2018
Everolimus Initiation With Early Calcineurin Inhibitor Withdrawal in De Novo Heart Transplant Recipients: Long-term Follow-up From the Randomized SCHEDULE Study.
    Transplantation, 2020, Volume: 104, Issue:1

    Topics: Adult; Calcineurin Inhibitors; Coronary Artery Disease; Coronary Vessels; Cyclosporine; Dose-Response Relationship, Drug; Everolimus; Female; Follow-Up Studies; Glomerular Filtration Rate; Glucocorticoids; Graft Rejection; Graft Survival; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Randomized Controlled Trials as Topic; Ultrasonography, Interventional

2020
Ten-year results of a randomized trial comparing tacrolimus versus cyclosporine a in combination with mycophenolate mofetil after heart transplantation.
    Transplantation, 2013, Feb-27, Volume: 95, Issue:4

    Topics: Adult; Chi-Square Distribution; Coronary Artery Disease; Cyclosporine; Drug Monitoring; Drug Therapy, Combination; Female; Germany; Graft Rejection; Graft Survival; Heart Transplantation; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Risk Factors; Tacrolimus; Time Factors; Treatment Outcome; Young Adult

2013
Use of rapamycin slows progression of cardiac transplantation vasculopathy.
    Circulation, 2003, Jul-08, Volume: 108, Issue:1

    Topics: Arterial Occlusive Diseases; Autoantibodies; Cardiac Catheterization; Cohort Studies; Coronary Artery Disease; Cyclosporine; Disease Progression; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Infections; Male; Middle Aged; Neoplasms; Prospective Studies; Renal Insufficiency; Sirolimus; Survival Analysis; Treatment Outcome

2003
Cardiovascular risk factors and estimated risk for CAD in a randomized trial comparing calcineurin inhibitors in renal transplantation.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2003, Volume: 3, Issue:8

    Topics: Calcineurin Inhibitors; Coronary Artery Disease; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Prospective Studies; Risk Factors; Survival Analysis; Tacrolimus

2003
A 10-year experience with intravenous thymoglobuline in induction of immunosuppression following heart transplantation.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 1999, Volume: 18, Issue:12

    Topics: Adult; Analysis of Variance; Antilymphocyte Serum; Azathioprine; Coronary Artery Disease; Cyclosporine; Female; Heart Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Injections, Intravenous; Lymphocyte Subsets; Male; Mycophenolic Acid; Prednisone; Retrospective Studies; T-Lymphocytes

1999

Other Studies

46 other study(ies) available for cyclosporine and Coronary Artery Disease

ArticleYear
Continuous cyclosporine a infusion in patients with severe Kawasaki disease.
    Pediatrics international : official journal of the Japan Pediatric Society, 2022, Volume: 64, Issue:1

    Topics: C-Reactive Protein; Coronary Artery Disease; Cyclosporine; Humans; Immunoglobulins, Intravenous; Infant; Mucocutaneous Lymph Node Syndrome; Treatment Outcome

2022
Infarct Size With Incremental Global Myocardial Ischemia Times: Cyclosporine A in Donation After Circulatory Death Rat Hearts.
    Transplantation proceedings, 2023, Volume: 55, Issue:7

    Topics: Animals; Coronary Artery Disease; Cyclosporine; Heart; Heart Transplantation; Myocardial Infarction; Rats; Tissue Donors

2023
Improving coronary artery outcomes for children with Kawasaki disease.
    Lancet (London, England), 2019, 03-16, Volume: 393, Issue:10176

    Topics: Child; Coronary Artery Disease; Cyclosporine; Humans; Immunoglobulins, Intravenous; Mucocutaneous Lymph Node Syndrome

2019
Cyclosporine and coronary outcomes in Kawasaki disease.
    The Journal of pediatrics, 2019, Volume: 210

    Topics: Coronary Artery Disease; Coronary Vessels; Cyclosporine; Humans; Immunoglobulins, Intravenous; Mucocutaneous Lymph Node Syndrome

2019
The carnitine-butyrobetaine-TMAO pathway after cardiac transplant: Impact on cardiac allograft vasculopathy and acute rejection.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2019, Volume: 38, Issue:10

    Topics: Acute Disease; Adult; Aged; Betaine; Carnitine; Coronary Artery Disease; Cyclosporine; Everolimus; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Methylamines; Microbiota; Middle Aged; Postoperative Complications

2019
Characteristics of cardiac allograft vasculopathy induced by immunomodulation in the miniature Swine.
    Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia, 2015, Volume: 21, Issue:1

    Topics: Animals; Cell Proliferation; Coronary Artery Disease; Coronary Vessels; Cyclosporine; Disease Models, Animal; Genetic Markers; Heart Transplantation; Histocompatibility; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; Immunosuppressive Agents; In Situ Hybridization, Fluorescence; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Severity of Illness Index; Swine; Swine, Miniature; Time Factors; Transplantation, Heterotopic; Y Chromosome

2015
Expression of NO Synthase Under Medication with Cyclosporine A, Mycophenolate Mofetil, and Tacrolimus during Development of Transplant Vasculopathy on Rat Cardiac Allograft.
    Cardiovascular therapeutics, 2016, Volume: 34, Issue:4

    Topics: Allografts; Animals; Coronary Artery Disease; Coronary Vessels; Cyclosporine; Disease Models, Animal; Down-Regulation; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Mycophenolic Acid; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Rats, Inbred Lew; Tacrolimus; Time Factors

2016
Features of cardiac allograft coronary endothelial dysfunction.
    The American journal of cardiology, 2009, Apr-15, Volume: 103, Issue:8

    Topics: Adult; Coronary Artery Disease; Cyclosporine; Endothelial Cells; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Nitric Oxide; Ultrasonography, Interventional

2009
Cyclosporine C2 levels have impact on incidence of rejection in de novo lung but not heart transplant recipients: the NOCTURNE study.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2009, Volume: 28, Issue:9

    Topics: Adult; Area Under Curve; Blood Pressure; Cardiomyopathies; Coronary Artery Disease; Creatinine; Cyclosporine; Cystic Fibrosis; Emphysema; Female; Glomerular Filtration Rate; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Monitoring, Physiologic; Pulmonary Disease, Chronic Obstructive

2009
Cardiac allograft vasculopathy compared by intravascular ultrasound sonography: everolimus to mycophenolate mofetil--one single-center experience.
    Transplantation proceedings, 2012, Volume: 44, Issue:4

    Topics: Adult; Aged; Coronary Artery Disease; Cyclosporine; Drug Therapy, Combination; Everolimus; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Linear Models; Male; Middle Aged; Multivariate Analysis; Mycophenolic Acid; Predictive Value of Tests; Risk Assessment; Risk Factors; Sirolimus; Steroids; Taiwan; Time Factors; Treatment Outcome; Ultrasonography, Interventional

2012
Two good reasons for an angiotensin-II type 1 receptor blockade with losartan after cardiac transplantation: reduction of incidence and severity of transplant vasculopathy.
    Transplant international : official journal of the European Society for Organ Transplantation, 2003, Volume: 16, Issue:1

    Topics: Acute Disease; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Coronary Artery Disease; Cyclosporine; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Incidence; Losartan; Models, Animal; Postoperative Complications; Rats; Rats, Inbred F344; Rats, Inbred Lew; Receptor, Angiotensin, Type 1; Severity of Illness Index

2003
Longer-term risks associated with 10-year survival after heart transplantation in the cyclosporine era.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2003, Volume: 22, Issue:10

    Topics: Adult; Age Factors; Case-Control Studies; Coronary Artery Disease; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Heart Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Multivariate Analysis; Obesity; Postoperative Complications; Risk Factors; Sex Factors; Time Factors

2003
Analysis of survivors more than 10 years after heart transplantation in the cyclosporine era: Stanford experience.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2004, Volume: 23, Issue:2

    Topics: Adult; Cohort Studies; Coronary Artery Disease; Cyclosporine; Diabetes Mellitus; Female; Graft Rejection; Heart Transplantation; Humans; Hyperlipidemias; Hypertension; Immunosuppressive Agents; Incidence; Male; Neoplasms; Registries; Renal Insufficiency; Survival Analysis; Survival Rate; Time Factors

2004
Inhibition of graft coronary arteriosclerosis after heart transplantation.
    The American surgeon, 2004, Volume: 70, Issue:10

    Topics: Animals; Coronary Artery Disease; Coronary Vessels; Cyclosporine; Dose-Response Relationship, Drug; Graft Occlusion, Vascular; Graft Rejection; Heart Transplantation; Immunosuppressive Agents; Models, Animal; Rats; Rats, Inbred ACI; Rats, Inbred Lew; Tunica Intima; Tunica Media

2004
Cyclosporine treatment of high dose and long duration reduces the severity of graft coronary artery disease in rodent cardiac allografts.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2005, Volume: 24, Issue:4

    Topics: Animals; Coronary Artery Disease; Coronary Vessels; Cyclosporine; Disease Models, Animal; Dose-Response Relationship, Drug; Ectodysplasins; Follow-Up Studies; Genes, MHC Class II; Graft vs Host Reaction; Heart Transplantation; Immunohistochemistry; Immunosuppressive Agents; Macrophages; Male; Membrane Proteins; Rats; Rats, Inbred ACI; Transplantation, Homologous; Treatment Outcome; Tunica Intima

2005
Cyclosporine mitigates graft coronary artery disease in murine cardiac allografts: description and validation of a novel fully allogeneic model.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2005, Volume: 24, Issue:4

    Topics: Animals; Chromatography, Liquid; Coronary Artery Disease; Coronary Vessels; Cyclosporine; Disease Models, Animal; Dose-Response Relationship, Drug; Follow-Up Studies; Gas Chromatography-Mass Spectrometry; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Male; Mice; Mice, Inbred C57BL; Monocytes; Myocytes, Cardiac; Transplantation, Homologous; Treatment Outcome

2005
Ten- and 20-year survivors of pediatric orthotopic heart transplantation.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2006, Volume: 25, Issue:3

    Topics: Actuarial Analysis; Adolescent; Bacterial Infections; Cardiomyopathies; Child; Child, Preschool; Coronary Artery Disease; Cyclosporine; Female; Graft Rejection; Heart Defects, Congenital; Heart Transplantation; Humans; Immunosuppressive Agents; Infant; Lymphoproliferative Disorders; Male; Reoperation; Retrospective Studies; Survival Analysis; Survivors; Tacrolimus

2006
Early proliferation of medial smooth muscle cells in coronary arteries of rabbit cardiac allografts during immunosuppression with cyclosporine A.
    Transplantation proceedings, 1995, Volume: 27, Issue:3

    Topics: Animals; Cell Division; Coronary Artery Disease; Cyclosporine; Graft Occlusion, Vascular; Graft Rejection; Heart Transplantation; Muscle, Smooth, Vascular; Rabbits; Time Factors

1995
[An experimental study of coronary arteriosclerosis after heart transplantation].
    [Zasshi] [Journal]. Nihon Kyobu Geka Gakkai, 1993, Volume: 41, Issue:10

    Topics: Animals; Coronary Artery Disease; Cyclosporine; Graft Rejection; Heart Transplantation; Immunosuppressive Agents; Lipids; Male; Rats; Rats, Inbred F344; Rats, Inbred Lew

1993
[Effects of acute rejection on the endothelium-dependent relaxation of coronary arteries of the transplanted heart in dogs].
    Annales de chirurgie, 1995, Volume: 49, Issue:8

    Topics: Acute Disease; Animals; Coronary Artery Disease; Coronary Vessels; Cyclosporine; Dogs; Endothelium, Vascular; Graft Rejection; Heart Transplantation; Immunosuppressive Agents; Transplantation, Heterotopic; Vasodilation

1995
No coronary atherosclerotic changes were found after heart transplantation in tolerance-induced rats.
    Transplantation proceedings, 1996, Volume: 28, Issue:3

    Topics: Animals; Blood Transfusion; Coronary Artery Disease; Cyclosporine; Heart Transplantation; Immune Tolerance; Immunosuppression Therapy; Immunosuppressive Agents; Male; Postoperative Complications; Rats; Rats, Inbred F344; Rats, Inbred Lew; Rats, Inbred Strains; Transplantation, Homologous; Transplantation, Isogeneic

1996
Cyclosporine a inhibits tissue factor expression in monocytes/macrophages.
    Blood, 1996, Nov-15, Volume: 88, Issue:10

    Topics: Biological Transport; Blood Coagulation Factors; Cell Nucleus; Cells, Cultured; Coronary Artery Disease; Cyclosporine; Depression, Chemical; Gene Expression Regulation; Heart Transplantation; Humans; Lipopolysaccharides; Macrophages; Monocytes; NF-kappa B; Postoperative Complications; Protein Binding; Thromboplastin; Transcription, Genetic

1996
L-arginine prevents heart transplant arteriosclerosis by modulating the vascular cell proliferative response to insulin-like growth factor-I and interleukin-6.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 1996, Volume: 15, Issue:12

    Topics: Animals; Antineoplastic Agents; Aorta; Arginine; Coronary Artery Disease; Coronary Vessels; Cyclosporine; Graft Rejection; Heart Transplantation; Histocompatibility Antigens Class II; Hyperplasia; Immunosuppressive Agents; Insulin-Like Growth Factor I; Interleukin-6; Macrophages; Male; Nitric Oxide; Postoperative Complications; Rabbits; T-Lymphocytes; Transplantation, Homologous

1996
Inhibition of transplant coronary arteriosclerosis in rabbits by chronic estradiol treatment is associated with abolition of MHC class II antigen expression.
    Circulation, 1996, Dec-15, Volume: 94, Issue:12

    Topics: Animals; Coronary Artery Disease; Cyclosporine; Estradiol; Graft Rejection; Heart Transplantation; Histocompatibility Antigens Class II; Immunohistochemistry; Immunosuppressive Agents; Macrophages; Male; Postoperative Complications; Rabbits; T-Lymphocytes; Transplantation, Homologous; Tunica Intima

1996
Adhesion molecule P-selectin and vascular cell adhesion molecule-1 in enhanced heart allograft arteriosclerosis in the rat.
    Circulation, 1997, Jan-07, Volume: 95, Issue:1

    Topics: Acute Disease; Animals; Chronic Disease; Coronary Artery Disease; Coronary Vessels; Cyclosporine; Endothelium, Vascular; Graft Rejection; Heart Transplantation; Linear Models; P-Selectin; Rats; Rats, Inbred Strains; Rats, Inbred WF; Vascular Cell Adhesion Molecule-1

1997
Role of hypercholesterolemia in accelerated transplant coronary vasculopathy: results of surgical therapy with partial ileal bypass in rabbits undergoing heterotopic heart transplantation.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 1997, Volume: 16, Issue:4

    Topics: Animals; Cholesterol; Cholesterol, Dietary; Coronary Artery Disease; Coronary Disease; Coronary Vessels; Cyclosporine; Disease Models, Animal; Heart Transplantation; Hypercholesterolemia; Immunosuppressive Agents; Male; Postoperative Complications; Rabbits; Risk Factors

1997
Inducible nitric oxide synthase expression in coronary arteries of transplanted human hearts with accelerated graft arteriosclerosis.
    The American journal of pathology, 1997, Volume: 151, Issue:4

    Topics: Adolescent; Adult; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Coronary Artery Disease; Coronary Vessels; Cyclosporine; Enzyme Induction; Heart Transplantation; Humans; Immunohistochemistry; Immunosuppressive Agents; In Situ Hybridization; Macrophages; Middle Aged; Myocardium; Nitric Oxide Synthase; RNA, Messenger

1997
Vascular effects of cyclosporin A and acute rejection in canine heart transplantation.
    The Annals of thoracic surgery, 1997, Volume: 64, Issue:5

    Topics: Acetylcholine; Acute Disease; Adenosine Diphosphate; Animals; Coronary Artery Disease; Coronary Circulation; Coronary Vessels; Cyclosporine; Dinoprost; Dogs; Dose-Response Relationship, Drug; Endothelium, Vascular; Factor VIII; Graft Rejection; Heart Transplantation; Immunoenzyme Techniques; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; In Vitro Techniques; Muscle, Smooth, Vascular; Myocardium; Nitroprusside; Serotonin; Thrombin; Transplantation, Heterotopic; Tunica Intima; Vasoconstriction; Vasodilation

1997
Effect of low molecular weight heparin on suppression of chronic graft vascular disease in a rat cardiac allograft model.
    Transplantation proceedings, 1998, Volume: 30, Issue:4

    Topics: Anastomosis, Surgical; Animals; Aorta, Abdominal; Chronic Disease; Coronary Artery Disease; Coronary Vessels; Cyclosporine; Fibrinolytic Agents; Heart Transplantation; Heparin, Low-Molecular-Weight; Immunosuppressive Agents; Male; NG-Nitroarginine Methyl Ester; Postoperative Complications; Rats; Rats, Inbred ACI; Rats, Inbred Strains; Transplantation, Heterotopic; Transplantation, Homologous; Vena Cava, Inferior

1998
Effect of cyclosporine on chronic graft vascular disease in a rat cardiac isograft model.
    Transplantation proceedings, 1998, Volume: 30, Issue:4

    Topics: Animals; Coronary Artery Disease; Cyclosporine; Fibrinolytic Agents; Heart Transplantation; Heparin, Low-Molecular-Weight; Immunosuppressive Agents; Male; Nitrates; Nitrites; Postoperative Complications; Rats; Rats, Inbred ACI; Transplantation, Heterotopic; Transplantation, Isogeneic

1998
Inhibitory effect of Multiglycosidorum tripterygii on coronary arteriosclerosis after heart transplantation.
    Transplantation, 1998, Jun-15, Volume: 65, Issue:11

    Topics: Animals; Coronary Artery Disease; Coronary Vessels; Cyclosporine; Drugs, Chinese Herbal; Heart Transplantation; Immunosuppressive Agents; Myocardium; Platelet-Derived Growth Factor; Postoperative Complications; Rats; Rats, Inbred Lew; Rats, Wistar; RNA, Messenger; Tripterygium

1998
Implication of HLA mismatch in the clinical outcome of orthotopic heart transplantation.
    Transplantation proceedings, 1998, Volume: 30, Issue:5

    Topics: Adolescent; Adult; Antilymphocyte Serum; Azathioprine; Child; Coronary Artery Disease; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Heart Function Tests; Heart Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Postoperative Complications; Prednisone; Retrospective Studies; Treatment Outcome

1998
Coronary arteriosclerosis did not occur in the transplanted hearts of tolerance-induced rats: analysis from platelet-derived growth factor expression.
    Transplantation proceedings, 1998, Volume: 30, Issue:7

    Topics: Animals; Blood Transfusion; Coronary Artery Disease; Cyclosporine; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppression Therapy; Male; Platelet-Derived Growth Factor; Rats; Rats, Inbred F344; Rats, Inbred Lew; Rats, Inbred Strains; Time Factors; Transplantation, Homologous; Transplantation, Isogeneic

1998
The detection of chronic heart graft rejection by 31P NMR spectroscopy.
    Surgery today, 1999, Volume: 29, Issue:2

    Topics: Adenosine Triphosphate; Animals; Chronic Disease; Coronary Artery Disease; Coronary Vessels; Cyclosporine; Graft Rejection; Graft Survival; Heart Transplantation; Magnetic Resonance Spectroscopy; Myocardium; Phosphocreatine; Phosphorus; Phosphorus Isotopes; Rats; Rats, Inbred F344; Rats, Inbred Lew; Transplantation, Homologous

1999
Multiglycosidorum tripterygii, a new immunosuppressant, supresses coronary arteriosclerosis after heart transplantation.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 1999, Volume: 18, Issue:3

    Topics: Animals; Blotting, Northern; Coronary Artery Disease; Coronary Vessels; Cyclosporine; Graft Rejection; Heart Transplantation; Immunosuppressive Agents; Male; Platelet-Derived Growth Factor; Polymerase Chain Reaction; Rats; Rats, Inbred Lew; Rats, Wistar; RNA; Transplantation, Homologous

1999
Relation between long-term steroid treatment after heart transplantation, hypofibrinolysis and myocardial microthrombi generation.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 1999, Volume: 18, Issue:7

    Topics: Azathioprine; Biopsy; Coronary Artery Disease; Cyclosporine; Drug Therapy, Combination; Female; Fibrinolysis; Glucocorticoids; Heart Diseases; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardium; Postoperative Care; Prednisone; Thrombosis; Time Factors

1999
Late multiglycosidorum tripterygium treatment ameliorates established graft coronary arteriosclerosis after heart transplantation in the rat.
    Transplantation proceedings, 1999, Volume: 31, Issue:5

    Topics: Animals; Coronary Artery Disease; Cyclosporine; Drugs, Chinese Herbal; Graft Rejection; Heart Transplantation; Immunosuppressive Agents; Male; Postoperative Complications; Rats; Rats, Inbred Lew; Rats, Inbred WKY

1999
Effects of immunosuppressants on platelet-derived growth factor-A chain mRNA expression and coronary arteriosclerosis in rat cardiac allografts.
    Japanese circulation journal, 1999, Volume: 63, Issue:4

    Topics: Animals; Coronary Artery Disease; Cyclosporine; Drugs, Chinese Herbal; Graft Rejection; Guanidines; Heart Transplantation; Immunosuppressive Agents; Male; Myocardium; Platelet-Derived Growth Factor; Rats; Rats, Wistar; RNA, Messenger; Transplantation, Homologous; Tripterygium

1999
FTY720, a new immunosuppressant, promotes long-term graft survival and inhibits the progression of graft coronary artery disease in a murine model of cardiac transplantation.
    Circulation, 1999, Sep-21, Volume: 100, Issue:12

    Topics: Animals; Coronary Artery Disease; Cyclosporine; Disease Progression; Fingolimod Hydrochloride; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Interferon-gamma; Interleukin-2; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Postoperative Complications; Propylene Glycols; Sphingosine; T-Lymphocytes, Cytotoxic

1999
Inhibitory effect of triptolide on platelet derived growth factor-A and coronary arteriosclerosis after heart transplantation.
    Transplantation proceedings, 1999, Volume: 31, Issue:7

    Topics: Animals; Coronary Artery Disease; Coronary Vessels; Cyclosporine; Diterpenes; Epoxy Compounds; Gene Expression Regulation; Heart Transplantation; Immunosuppressive Agents; Male; Phenanthrenes; Platelet-Derived Growth Factor; Postoperative Complications; Rats; Rats, Inbred Lew; Rats, Inbred Strains; Transplantation, Homologous

1999
Intravascular ultrasound for assessment of coronary allograft vasculopathy.
    Zeitschrift fur Kardiologie, 2000, Volume: 89 Suppl 9

    Topics: Clinical Trials as Topic; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Cyclosporine; Follow-Up Studies; Heart Transplantation; Humans; Immunosuppressive Agents; Multicenter Studies as Topic; Practice Guidelines as Topic; Prognosis; Prospective Studies; Research; Risk Factors; Tacrolimus; Time Factors; Ultrasonography, Interventional

2000
Cyclosporine does not enhance the development of accelerated coronary artery disease: experimental study in a rat cardiac transplant model.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2002, Volume: 21, Issue:4

    Topics: Animals; Cell Survival; Coronary Artery Disease; Coronary Restenosis; Cyclosporine; Disease Models, Animal; Dose-Response Relationship, Drug; Graft Rejection; Graft Survival; Heart Rate; Heart Transplantation; Immunosuppressive Agents; Male; Models, Cardiovascular; Random Allocation; Rats; Rats, Inbred F344; Rats, Inbred Lew; Time Factors; Treatment Outcome; Weight Gain; Withholding Treatment

2002
Paclitaxel and cyclosporine A show supra-additive antiproliferative effects on smooth muscle cells by activation of protein kinase C.
    Basic research in cardiology, 2002, Volume: 97, Issue:2

    Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Cattle; Cell Division; Cells, Cultured; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Cyclosporine; Enzyme Activation; Immunosuppressive Agents; Muscle, Smooth, Vascular; Paclitaxel; Protein Kinase C

2002
[Organ transplantation].
    [Zasshi] [Journal]. Nihon Kyobu Geka Gakkai, 1992, Volume: 40, Issue:5

    Topics: Adult; Aged; Animals; Brain Death; Catheterization, Swan-Ganz; Coronary Artery Disease; Cyclosporine; Denervation; Dogs; Female; Heart; Heart Transplantation; Herpesviridae Infections; Humans; Immunosuppression Therapy; Lung; Lung Transplantation; Male; Middle Aged; Myocardial Infarction; Organ Transplantation; Postoperative Complications; Rats; Tissue Survival

1992
Immunologically induced coronary artery stenosis in allografts after heart and heart-lung transplantation in rats.
    Surgery today, 1992, Volume: 22, Issue:3

    Topics: Animals; Coronary Artery Disease; Coronary Vessels; Cyclosporine; Graft Rejection; Graft Survival; Heart Transplantation; Heart-Lung Transplantation; Male; Rats; Rats, Inbred F344

1992
Investigation of heart transplant coronary atherosclerosis.
    Circulation, 1992, Volume: 85, Issue:3

    Topics: Coronary Artery Disease; Coronary Vessels; Cyclosporine; Heart Transplantation; Humans; Immunosuppression Therapy; Risk Factors; Ultrasonography

1992